期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

从新近临床试验看利尿剂在高血压治疗中的作用 被引量：1

原文传递
导出
摘要 利尿剂是传统的降压药,自20世纪60年代以来,在退伍军人管理局降压协作研究、老年收缩期高血压项目等一系列大样本临床试验中,均证实利尿剂能显著减少高血压患者的心脑血管事件,对于老年单纯收缩期高血压患者来说优势更加显著。
作者 刘靖
机构地区 北京大学人民医院心内科
出处 《中华高血压杂志》 CAS CSCD 北大核心 2016年第6期518-520,共3页 Chinese Journal of Hypertension
关键词 临床试验 降压药物 噻嗪类利尿剂 阿米洛利 钙拮抗剂 血压监测 心血管事件 次要终点 替米沙坦 协作研究
分类号 R544.1 [医药卫生—心血管疾病]
  • 相关文献

参考文献8

  • 1利尿剂治疗高血压的中国专家共识[J].中华高血压杂志,2011,19(3):214-222. 被引量：58
  • 2Wang W, Ma L, Zhang Y, et al. The combination of amlodipine and angiotensin receptor blocker or diuretics in high risk hyperten sive patients: rationale, design and baseline characteristics [J]. J Hum Hypertens,2011,25(4) :271-277.
  • 3Ma L, Wang W, Zhao Y, et al. Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study[J]. Am J Cardiovasc Drugs, 2012,12(2): 137-142.
  • 4Brown M, Williams B, Morant S, et al. Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY 3) : a parallel- group, double-blind randomised phase 4 trial[J]. Lancet Diabetes Endocrinol. 2016,4(2) : 136-470.
  • 5Williams B, MacDonald T, Morant S, et al. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treat ment for drug-resistant hypertension (PATHWAY-2) : a random- ised, double-blind, crossover trial[J]. Lancet, 2015,386 (10008) : 2059-2069.
  • 6Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure- lowering on outcome incidence in hypertension: 5. Head-to-head comparisons of various classes of antihypertensive drugs-overview and meta-analyses[J]. J Hypertens,20J5,33(7) :1321-1341.
  • 7陈鲁原.临床应用噻嗪样与噻嗪型利尿剂的思考[J].中华高血压杂志,2015,23(7):608-611. 被引量：7
  • 8Olde Engberink R, Frenkel W, van den Bogaard B, et al. Effects of thiazide-type and thiazide-like diuretics on cardiovascular events and mortality[J]. Hypertension,2015,65(5) : 1033-1040.

二级参考文献82

  • 1谭静,华琦,刘荣坤,杨峥.动态血压监测比较北京降压0号和氢氯噻嗪的降压疗效[J].首都医科大学学报,2006,27(2):222-225. 被引量：13
  • 2Ernst ME, Carter BL, Zheng S, et al. Meta-analysis of dose-response characteristics of hydrochlorothiazide and dhlorthalidone: effects on systolic blood pressure and potassium[J]. Am J Hypertens,2010,23(4): 440-446.
  • 3London GM, Sehmieder R, Calvo C, et al. On behalf of the XCELLENT study investigators, indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT Study[J]. Am J Hypertens,2006,19(2) :113-121.
  • 4Emeriau JP, Knauf H, Pujadas JO, et al. A comparison of indapamide SR 1.5 mg with both amlodipine 5 mg and hydrochlorotiazide 25 mg in elderly hypertensive patients: a randomized doubleblind controlled study[J]. J Hypertens, 2001,19(2) : 343-350.
  • 5Veterans Administration Cooperative Study Group on antihypertensive agents. Effects of treatment on morbidity in hypertension: Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg[J]. JAMA,1967,202(11):1028-1034.
  • 6Veterans Administration Cooperative Study Group on antihyper- tensive agents. Effects of treatment on morbidity in hypertension Ⅱ: Results in patients with diastolic blood pressures averaging 90 through 114 mm Hg[J]. JAMA,1970,213(7):1143-1152.
  • 7Veterans Administration Cooperative Study Group on antihyper- tensive agents. Effects of treatment on morbidity in hypertension Ⅲ : Influence of age, diastolic blood pressures and prior cardiovascular disease. Further analysis of side effeets[J]. Circulation, 1972,45(5) : 991-1004.
  • 8Hypertension Detection and Follow-up Program cooperative Group. Five-year findings of the hypertension detection and follow-up program[J]. JAMA,1979,242(23) :2562-2571.
  • 9The ALLHAT Officers and Coordinators for the ALLHAT Col- laborative Research Group. Major outcomes in high-risk hyper- tensive patients randomized to angiotensin-converting enzyme in- hibitor or calcium channel blocker vs diuretic[J]. JAMA, 2002, 288(23) : 2981-2997.
  • 10Blood pressure lowering treatment trialists collaboration. Effects of different blood pressure lowering regiments on major cardiovascular events: results of prospectively designed overviews of randomised trials[J]. Lancet,2003,362(9395) :1527-1545.

共引文献62

同被引文献20

引证文献1

二级引证文献1

中华高血压杂志
2016年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部